Ayse Suleyman

Dr. Ayse Suleyman


Research Focus & Metrics

Academic Career Length

8Years (2019-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 February 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
EYEsra YUCEL
Esra YUCEL
ASAyse Suleyman
Ayse Suleyman
ZDZeynep Hizli Demirkale
Zeynep Hizli Demirkale
NGNermin Guler
Nermin Guler
ZTZeynep Ulker Tamay
Zeynep Ulker Tamay
COCevdet Ozdemir
Cevdet Ozdemir

12 June 2019 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
EYEsra YUCEL
Esra YUCEL
SCSevgi Sipahi Cimen
Sevgi Sipahi Cimen
SVSelin Varol
Selin Varol
ASAyse Suleyman
Ayse Suleyman
COCevdet Ozdemir
Cevdet Ozdemir
ZTZeynep Ulker Tamay
Zeynep Ulker Tamay

1 April 2022 in Journal of Asthma and Allergy
Verified
Journal Article
Open access
PDF file
ASAyse Suleyman
Ayse Suleyman
ZTZeynep Tamay
Zeynep Tamay
NGNermin Guler
Nermin Guler
Background: Local anesthetics (LA) are relatively safe and rarely cause immediate hypersensitivity reactions. The data on immediate LA hypersensitivity and its risk factors in children are limited. Aim: To evaluate risk factors of immediate LA hypersensitivity. Methods: The retrospective case-controlled study included 17 patients with confirmed immediate LA hypersensitivity. For each patient, three age- and gender-matched control subjects were included in the study. LA hypersensitivity was excluded by skin tests and subcutaneous drug provocation tests in all control subjects. Results: The most common allergic assessment in the patient/control group was for lidocaine (n=5; 29.4%, vs n=23; 45.1%). Suspected LA hypersensitivity reactions were found to be associated with cutaneous manifestations in 14 (82.4%) patients and in 7 (13.7%) of the controls. A history of exposure to local anesthetics twice or more was present in 11 (64.7%) patients vs 6 (11.8%) controls. In conditional regression analysis, repeated LA exposure (≥ 2) and cutaneous findings were determined as significant risk factors (Odds Ratio [OR]:5.7; 95% Confidence Interval [CI]:1.2– 27.1; P=0.029 and (OR:17.3; 95% CI:3.6– 82.5; P< 0.001, respectively). Conclusion: Cutaneous manifestations and a history of LA exposure twice or more were predictive factors for LA allergy confirmed by skin test in children.

28 June 2021 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
ASAyse Suleyman
Ayse Suleyman
EYEsra YUCEL
Esra YUCEL
SCSevgi Sipahi Cimen
Sevgi Sipahi Cimen
ZDZeynep Hizli Demirkale
Zeynep Hizli Demirkale
COCevdet Ozdemir
Cevdet Ozdemir
NGNermin Guler
Nermin Guler

12 August 2020 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
PDF file
SCSevgi Sipahi Cimen
Sevgi Sipahi Cimen
EYEsra YUCEL
Esra YUCEL
DODeniz Ozceker
Deniz Ozceker
ASAyse Suleyman
Ayse Suleyman
ZDZeynep Hizli Demirkale
Zeynep Hizli Demirkale
ZTZeynep Ulker Tamay
Zeynep Ulker Tamay

15 June 2022 in Pediatric Allergy and Immunology
Verified
Journal Article
Closed access
EYEsra YUCEL
Esra YUCEL
ÇKÇağla Karavaizoğlu
Çağla Karavaizoğlu
ZDZeynep Hizli Demirkale
Zeynep Hizli Demirkale
KDKAZIM OKAN DOLU
KAZIM OKAN DOLU
ASAyse Suleyman
Ayse Suleyman
ZTZeynep Ulker Tamay
Zeynep Ulker Tamay